Article
SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells.
International journal of molecular sciences - 24 Jan 2022
Rosato Barbara Eleni, Marra Roberta, D'Onofrio Vanessa, Del Giudice Federica, Della Monica Simone, Iolascon Achille, Andolfo Immacolata, Russo Roberta
Abstract excerpt
Biallelic pathogenic variants in the SEC23B gene cause congenital dyserythropoietic anemia type II (CDA II), a rare hereditary disorder hallmarked by ineffective erythropoiesis, hemolysis, erythroblast morphological abnormalities, and hypo-glycosylation of some red blood cell membrane proteins. Abnormalities in SEC23B, which encodes the homonymous cytoplasmic COPII (coat protein complex II) component, disturb the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
